← Back to Search

Sleep Extension Intervention for High Blood Pressure

N/A
Waitlist Available
Led By Kelly C Allison, Ph.D.
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 16 of the intervention
Awards & highlights

Study Summary

This trial will study how increased nighttime sleep can reduce obesity, improve wellbeing, and lower blood pressure. #sleepbetter #weightloss

Eligible Conditions
  • High Blood Pressure
  • Obesity
  • Sleep
  • Eating Disorders
  • Quality of Life

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 16 of the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 16 of the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of intervention session attendance
Percentage of participants who complete the study
Secondary outcome measures
Change in nighttime sleep duration
Change in weight

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sleep Extension InterventionExperimental Treatment1 Intervention
All participants will receive the 16-week sleep extension intervention aimed to lengthen nighttime sleep duration by at least 30-60 minutes per night. No prescription for daily calorie/dietary intake or physical activity will be provided in this study, except behaviors consistent with sleep hygiene recommendations.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep Extension
2017
N/A
~400

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,880,088 Total Patients Enrolled
Kelly C Allison, Ph.D.Principal InvestigatorUniversity of Pennsylvania
Philip Gehrman, Ph.D.Principal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals of advanced age being considered for this research project?

"The investigators of this research initiative are searching for study participants who are over the age of majority, yet younger than 50."

Answered by AI

Are there any specific qualifications needed to take part in this clinical experiment?

"The requirements for entry into this trial are obesity and being between 18-50 years old. Currently, the study is looking to recruit approximately 10 participants."

Answered by AI

Are there available slots for participants in this experiment?

"Evidenced on clinicaltrials.gov, this trial is still open to applicants and was initially posted on February 7th 2023 with the most recent update coming a month later."

Answered by AI

What is the maximum capacity of individuals that can participate in this research?

"Affirmative, the trial is actively recruiting participants. The webpage on clinicaltrials.gov was first posted on February 7th 2023 and its most recent revision occurred March 7th 2023. 10 patients are required to be enrolled from a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
What site did they apply to?
University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

just looking for help.
PatientReceived 2+ prior treatments
~0 spots leftby Apr 2025